Published in

Wiley, Journal of Cellular Biochemistry, 2(114), p. 245-249, 2012

DOI: 10.1002/jcb.24362

Links

Tools

Export citation

Search in Google Scholar

Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis

Journal article published in 2012 by Jiezhong Chen, Ross Crawford ORCID, Yin Xiao ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Osteoarthristis is characterised by degenerative alterations of articular cartilage including both the degradation of extracellular matrix and the death of chondrocytes. The PI3K/Akt pathway has been demonstrated to involve in both processes. Inhibition of NF-κB reduces the degradation of extracellular matrix via decreased Matrix metalloproteinases production while inhibition of mTOR increased autophagy to reduce chondrocyte death. However, mTOR feedback inhibits the activity of the PI3K/Akt pathway and inhibition of mTOR could result in increased activity of the PI3K/Akt/NF-κB pathway. We proposed that the use of dual inhibitors of PI3K and mTOR could be a promising approach to more efficiently inhibit the PI3K/Akt pathway than rapamycin or PI3K inhibitor alone and produce better treatment outcome. J. Cell. Biochem. © 2012 Wiley Periodicals, Inc.